We recently showed that BZLF1, the gene encoding the Epstein-Barr virus (EBV) ZEBRA protein, was expressed in all eight nasopharyngeal carcinoma (NPC) specimens studied. We present here studies on the expression of EBV lyric cycle genes in the same eight NPC biopsies to determine if production of the ZEBRA transactivator could lead to a complete productive cycle. The tumour lesions exhibit a number of different patterns of limited lytic gene expression. In three out of eight tumours neither BRLF1 nor BMLF1 expression could be detected. Otherwise BMLF1 mRNA was expressed in all the other specimens. Three specimens also expressed BRLF1. Two specimens not only exhibited BZLF1, BMLF1 and BRLF1 transcripts, but also expressed the late gene BLLF1 which encodes the membrane protein gp220. The early gene product BBLF2 could not be detected in any of the eight NPC. However, expression of the late gene encoding the lyric truncated form of LMP1 (D1LMP) was found in seven of the eight NPC biopsies. Thus, it could be suggested that the EBV abortive lytic cycle occurred in most of the NPC studied.
Introduction
The Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis and has been associated with different malignancies: endemic Burkitt's lymphoma, 30% of Hodgkin's disease, B cell lymphomas in immunocompromised individuals, T cell lymphomas, nasopharyngeal carcinoma (NPC), and more recently with gastric carcinoma (Miller, 1990; Chen et al., 1993; Oda et al., 1993) . Viral genes expressed in EBVassociated tumours could contribute to carcinogenesis. In NPC, expression of latent viral genes has been observed: EBERs, EBNA1, LMP1 and -2 and a family of mRNAs transcribed rightward through the BamHI A (Gilligan et aL, 1990 (Gilligan et aL, , 1991 Fahraeus et aL, 1988; Young et al., 1988; Niedobitek et al., 1992; Brooks et al., 1992; Busson et al., 1992; Hittet al., 1989; Chen et al., 1992) .
Serological studies have shown that the clinical onset of NPC is preceded by the appearance of a high antibody titre to EA and VCA. The titres increase with the total tumour burden and the antibodies gradually decline with the response to therapy (Henle et al., 1973; de Th6, 1980) . This suggests that the expression of the lytic cycle is associated with the presence of the tumour. We have shown that most NPC patients (87 %) exhibit antibodies to the ZEBRA protein (this protein, also referred as EB1 or Zta, switches EB virus from the latent to the * Author for correspondence. Fax +33 1 45 59 70 09. productive cycle) (Joab et al., 1991) . We also demonstrated that the gene encoding the ZEBRA protein, BZLFI, was expressed in all NPC specimens studied Cochet et al., 1993) . In order to determine if expression of BZLF1 gives rise to complete or abortive productive cycle, RT-PCR analysis was performed to investigate the expression of early and late genes in eight tumour biopsies. Spliced lytic transcripts, easily distinguishable from genomic DNA were assayed: (1) the immediate early gene B RLF 1 encoding the R transactivator ; (2) the early gene BMLF1 encoding the M transactivator (Buisson et al., 1989) ; (3) BBLF2-BBLF3 encoding a primase associated factor (Farrell, 1989) ; and (4) BLLF 1 late gene encoding gp220/350 glycoproteins (Beisel et al., 1985; Tosoni-Pittoni et al., 1989) . We also investigated the expression of BNLF1 encoding the latent as well as the truncated form of LMP1, the latter being characteristic of the lytic cycle (Hudson et al., 1985) . The results presented here suggest that, in most of the cases, an abortive lytic cycle occurs in NPC. 
Preparation of probes.
Clones of EBV (B95-8) DNA in pBR322 were used (Dambaugh et al.. 1980) . Specific probes were prepared from the corresponding plasmids after digestion with the appropriate restriction enzymes. Fragments were purified twxce through 1% Nu Sieve GTG agarose gel (FMC), and then radiolabelled with the Prime-a-Gene system (Promega).
Amplification and analysis of cDNA. The eDNA samples (obtained from 200 ng of total RNA) were subjected to PCR using Taq DNA polymerase (Promega) and specific oligonucleotides ( Table 1 ). The cycle procedure was standardized for all reactions: denaturation for 5 min at 95 °C was followed by the addition of 2.5 U of the enzyme, then denaturation for 30 s at 95 °C, annealing for 1 min at 58 °C, and extension for 2 min at 72 °C for 30 cycles. Cycling was followed by 7 min extension at 72 °C. When specified, 2 ~tl of the PCR product were used for a second round of PCR.
PCR products were analysed by electrophoresis through a 1% agarose gel (Bioprobe systems) and Southern transfer onto Hybond-N membranes (Amersham). Detection of products was achieved by hybridization to a 32P-labelled probe.
When specified, DNA fragments were excised from the agarose gel, purified, made blunt-ended with the Klenow fragment of DNA polymerase, phosphorylated, inserted at the EeoRV site of plasmid pGEM-5ZF + (Promega) and sequenced with the Dyedeoxy terminator cycle sequencing kit (Applied Biosystems) on a model 373A automatic sequenccr.
Results

Analysis of the eDNA preparations
The same c D N A preparations were used in the present study as in the previous report on BZLF1 expression checked by P C R amplifications of the housekeeping gene hypoxanthine phosphoryltransferase, using as the sense primer 5
' T A T G G A C A G G A C T G A A C G T C and as the antisense primer 5' G T T G A G A G A T C A T C T -
The expected b a n d at 246 bp was observed in all biopsy samples ( Fig. 1) .
Analysis of BRLF1 immediate early transcripts
BRLF1 codes for the R transactivator and is transcribed into several m R N A species: one transcript of the entire genomic sequence and another with the 939 bp i n t r o n sequence spliced out ( M a n e t et al., 1989) . c D N A was amplified using an upstream primer in exon a (RSI) a n d a d o w n s t r e a m primer in exon b (RAS4). Two bands ( phorbol-13-acetate), a 443 bp band corresponding to copies of spliced transcripts and a 1383 bp band which could correspond to copies of unspliced transcripts or of viral genomic DNA. After two rounds of PCR using the same set of primers, cDNA was detected in three of the eight biopsies analysed, BP14, BP20 and BP40 (Fig. 2) .
Analysis of BMLF1 and BBLF2 early transcripts
The reading frame BMLF1-BSLF2 encodes the M transactivator of the lytic cycle which is transcribed into two kinds of mRNA. One of them consists of two exons with a spliced out of a small 106 bp intron (Buisson et al., 1989) . Copies of transcripts were amplified using an upstream primer in the first exon (MIS) and a downstream primer in the second exon (M2AS). Two bands were identified in the B95-8 positive control (Fig.  3) , one, 1502 bp, corresponding to the genomic product, and the other, 1396 bp, corresponding to the spliced transcript. Two rounds of PCR using the same set of primers demonstrated the presence of spliced product in five of the eight biopsies analysed, BP14, BP20, BP40, BP46 and BP8 (Fig. 3) . The BBLF2-BBLF3 reading frame encodes a primase associated factor (Farrell, 1989) : the gene is composed of two exons separated by a small 129 bp intron. Primers were designed to investigate BBLF2 gene transcription without competitive amplification of eventual contami-nating genomic DNA. The upstream primer (F3S) described a sequence across the splice junction between the two exons, and the downstream primer (F3AS) was chosen in exon b. A PCR product of 574bp was expected. In Fig. 4 , a band of the predicted size is observed in the positive control cDNA of B95-8 TPAtreated cells; however, there was no amplification product in any of the eight NPC tumour biopsies tested. After a second round of PCR, using the same set of primers, no amplification of the BBLF2 gene product could be detected in any of the NPC turnout biopsies (Fig. 4) .
Analysis of late transcripts coding for gp220 and LMP1
The BLLF1 reading frame encodes the principal components of the outer surface glycoproteins gp350 and gp220 (Beisel et al., 1985; Tosoni-Pittoni et al., 1989) . When the 591 bp intron of the BLLF1 transcript is spliced out of the RNA, the RNA codes for gp220. In the unspliced form, the RNA codes for gp350. The gp220 transcripts were amplified using an upstream primer (GPS) across the splice junction between exons a and b and a downstream primer (GPAS) in exon b. A PCR product of 516 bp was expected. After a first round of amplification (not shown), a band was visible only in the B95-8 positive control. After a second round of amplification using the same primers the results (Fig. 5) showed the presence of cDNA encoding gp220 in only two tumour biopsies, BP14 and BP20.
LMP1 is encoded by the BNLF1 reading frame: the gene contains three exons separated by two small introns of 76 and 78 bp. Two kinds of transcripts are expressed according to the state of virus cycle. A transcript containing the three exons is transcribed from the ED-L 1 promoter during the latent cycle, while an unspliced mRNA is transcribed from the ED-L1A promoter during the lytic cycle (Hudson et al., 1985) . The resulting late and truncated LMP is functionally distinct from normal LMP (Wang et al., 1988) . Primers were designed to distinguish these two types of transcripts.
Transcripts encoding the truncated form of the protein were amplified using the primer LMP2S in the intron between exons a and b downstream of the ED-L1A promoter, and the primer LMP1AS in the untranslated part of the cDNA downstream of exon c; a PCR product of 1054 bp was expected. Fig. 6A shows that after one round of PCR, the transcripts were present in all biopsies except tumour BP8. Since the cDNA encoding the truncated LMP is not spliced, it was important to demonstrate that genomic DNA was not detectable in our preparations. We amplified possible contaminating genomic DNA with an upstream primer in exon c (LMP-2CS) and a downstream primer (LMPGAS) localized downstream of the polyadenylation site; an amplified PCR product of 1524 bp was expected and a band of that size was observed when control DNA from B95-8 cells was used (Fig. 6B ). This clearly shows that genomic contamination could not account for the 1054bp molecules obtained after PCR amplification in the tumour biopsies. By using serial dilutions of known amounts of DNA and limiting PCR conditions (20 cycles of amplification) we established that amplification of the 1524 bp band is at least as efficient as amplification of the 1054 bp piece (not shown).
The transcripts encoding the latent form of LMP were analysed using a primer located in exon a (LMPS) and a primer (LMPEAS) overlapping the splice junction between exons c and b. After two rounds of PCR (Fig.  6C) , transcripts for the latent form of LMP1 (372 bp) were visualized in four of the eight biopsies, MD, BP38, BP40 and BP46. We also visualized a 450 bp band; sequencing of this product demonstrated that one intron was retained in this form.
Discussion
Previous work from our laboratory has demonstrated by in situ hybridization that NPC tumour cells exhibit expression of the BZLF1 gene, and by reverse PCR that spliced transcripts of the BZLF 1 gene were present in all the NPC biopsies analysed (eight specimens) (MartelRenoir et al., 1993; Cochet et al., 1993) . In the present study, by using the same cDNA preparations, we investigated the expression of EBV early and late genes. An overview of the results is shown in Table 2 : the tumour lesions exhibit differing patterns of limited lytic gene expression. In three out of eight tumours (BP30, BP38 and ME)) neither BRLF1 nor BMLF1 expression could be detected. Otherwise BMLF1 mRNA was expressed in all the other specimens. Three specimens also expressed BRLF1 (BP14, BP20 and BP40). Two specimens (BP14 and BP20) not only exhibit BZLF1, BMLF1 and BRLF1 transcripts, but also expressed the late gene BLLF1 which encodes the membrane protein gp220. Two rounds of 30 cycles of PCR were necessary to visualize these last cDNAs. Within the samples that we analysed, we did not observe transcripts from BZLF 1 (RaabTraub et al., 1983) . In previous work , we demonstrated by in situ hybridization that the transcripts encoding ZEBRA were confined to large epithelial tumour cells. We cannot rule out the possibility that the lytic RNAs are expressed both in the infiltrating lymphocytes and in the tumour cells. All the NPC biopsies did not appear to show transcription of the early BBLF2 BBLF3 reading frame, even after two rounds of PCR, indicating that this gene is not transcribed in NPC, at least not in a sufficient amount to be detected. Another gene, the lytic cycle BHRF1 mRNA, which is abundant in LCL, was also not detected by reverse PCR by Sam et al. (1993) in NPC.
In striking contrast with these observations is the expression of the late gene encoding the lytic truncated form of LMP 1, D 1LMP. Transcripts from this gene were found in seven of the eight NPC biopsies. Since this transcript has no intron, it was of importance to demonstrate that, in spite of the DNase 1 treatment, genomic DNA could not account for the band observed after RT-PCR. Amplification of the DNA with a primer located downstream of the polyadenylation signal showed that genomic contamination was not detectable. The transcripts encoding D1LMP are detectable in the biopsies after a single round of PCR; this could reflect either the abundance of the transcripts or a more effective amplification. Two rounds of PCR are required to visualize the equivalent latent LMP in the same biopsies although BNLF1 transcripts were described as being abundant in NPC biopsies (Gilligan et al., 1990) . Similarly, Brooks et al. (1992) also used nested PCR to detect copies of mRNA encoding LMP1 from NPC cultivated in nude mice. Transcripts of latent LMP were visualized in four of the eight biopsies. These observations are in agreement with previous studies on LMP expression in NPC which demonstrate heterogeneous expression of LMP between individual tumours, the expression varying from 20 to 80 % of cases Niedobitek et al., 1992; Fahraeus et al., 1988) . Stewart & Arrand (1993) also reported expression of LMP protein in seven of nine NPC biopsies by probing tissue sections with monoclonal antibodies, CS1-4, raised against a fusion protein between flgalactosidase and the carboxy terminus of LMP (Rowe et al., 1987) . However, these antibodies would also react with the truncated form of the LMP protein. Since D1LMP protein has no transformation-associated phenotypic effect in Rat-l cells, it is difficult to ascribe to this protein a crucial role in the development of an NPC tumour (Wang et al., 1988; Baichwal & Sugden, 1989) .
The findings that emerge from this work are that the EBV lytic cycle is reactivated in NPC, and that this productive cycle is often incomplete. The expression of lytic antigens varied among the individual tumours analysed. The block in the productive cycle could depend either on a defective viral protein, or on the permissivity of the tumour cell itself (Gradoville et al., 1990) . However, a feature common to most of the biopsies seems to be expression of the immediate early transactivator ZEBRA and the lyric form of LMP1.
A number of reports have shown that an abortive lytic cycle occurs in non-Hodgkin's lymphoma of immunocompromised patients (Katz et al., 1989; Pallesen et al., 1991 a; Bashir et al., 1993) . Similar results were observed in Hodgkin and Reed-Sternberg cells (Pallesen et al., 1991b; Bibeau et al., 1994 ). An abortive lytic cycle has also been reported to occur in gastric UCNT (Rowlands et al., 1993) . Our results also suggest that viral reactivation might be a general feature of NPC tumours. The proportion of turnout cells of the EBV related tumours supporting the abortive viral cycle has not been evaluated. Even if viral reactivation concerns only a small population of the primary tumour cells, characterization of lytic gene expression remains of interest since abortive lytic cycle in NPC might result in survival of the host cell allowing interaction of viral lytic proteins with cellular processes. It has been recently demonstrated that ZEBRA antigen is able to inhibit p53-dependent transactivation and to functionally and physically interact with the p65 subunit of the cellular factor NF-KB . The BMLF1 lytic gene has been demonstrated to exhibit transforming properties (Corbo et al., 1994) . Thus the deregulation of the programmed expression of the EBV lytic antigens could interfere with cellular functions and this may contribute to carcinogenesis.
